John S Davies (John Davies)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Venues

British journal of pharmacology

Nature immunology

Journal for immunotherapy of cancer

The British journal of dermatology

National Institutes of Health

University of Arizona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Institutes of Health Apr 11 2016

United States

Postdoctoral Fellow :: National Cancer Institute

National Institutes of Health

United States

Postbaccalaureate Fellow :: NHLBI

Education History

University of Arizona - May 05 2016

United States

PHD :: Immunobiology

Montana State University Bozeman

United States

BSC :: Cell Biology & Neuroscience

Publications

David Rutkowski, Rachel Scholey, John S Davies, Derek Pye, Fiona Blackhall, Richard Bruce Warren, Francisco Jimenez, Christopher Ernest Maitland Griffiths, Ralf Paus
EGFR/MEK inhibitor therapy induces a distinct inflammatory hair follicle response that includes a collapse of immune privilege. The British journal of dermatology (2024)
Gautham Gampa, Phillip Spinosa, Jennifer Getz, Yu Zhong, Wendy Halpern, Emel Esen, John S Davies, Cassie Chou, Mandy Kwong, Yingyun Wang, Teresita L Arenzana, Vittal Shivva, Mahrukh Huseni, Robert Hsieh, Jill Schartner, James T Koerber, Sascha Rutz, Iraj Hosseini
Preclinical and translational pharmacology of afucosylated anti-CCR8 antibody for depletion of tumour-infiltrating regulatory T cells. British journal of pharmacology 181 (13) (2024)
Gautham Gampa, Phillip Spinosa, Jennifer Getz, Yu Zhong, Wendy Halpern, Emel Esen, John S Davies, Cassie Chou, Mandy Kwong, Yingyun Wang, Teresita L Arenzana, Vittal Shivva, Mahrukh Huseni, Robert Hsieh, Jill Schartner, James T Koerber, Sascha Rutz, Iraj Hosseini
Preclinical and translational pharmacology of afucosylated anti-CCR8 antibody for depletion of tumour-infiltrating regulatory T cells. British journal of pharmacology (2024)
Gautham Gampa, Phillip Spinosa, Jennifer Getz, Yu Zhong, Wendy Halpern, Emel Esen, John S Davies, Cassie Chou, Mandy Kwong, Yingyun Wang, Teresita L Arenzana, Vittal Shivva, Mahrukh Huseni, Robert Hsieh, Jill Schartner, James T Koerber, Sascha Rutz, Iraj Hosseini
Preclinical and translational pharmacology of afucosylated anti-CCR8 antibody for depletion of tumour-infiltrating regulatory T cells. British journal of pharmacology 181 (13) (2024)
David Rutkowski, Rachel Scholey, John S Davies, Derek Pye, Fiona Blackhall, Richard Bruce Warren, Francisco Jimenez, Christopher Ernest Maitland Griffiths, Ralf Paus
EGFR/MEK inhibitor therapy induces a distinct inflammatory hair follicle response that includes a collapse of immune privilege. The British journal of dermatology (2024)
Kazusa Ishii, John S Davies, Andrew L Sinkoe, Kilyna A Nguyen, Scott M Norberg, Crystal P McIntosh, Tejas Kadakia, Carylinda Serna, Zachary Rae, Michael C Kelly, Christian S Hinrichs
Multi-tiered approach to detect autoimmune cross-reactivity of therapeutic T cell receptors. Science advances 9 (30) (2023)
Cristiane J Nunes-Santos, Hye Sun Kuehn, Brigette Boast, SuJin Hwang, Douglas B Kuhns, Jennifer Stoddard, Julie E Niemela, Danielle L Fink, Stefania Pittaluga, Mones Abu-Asab, John S Davies, Valarie A Barr, Tomoki Kawai, Ottavia M Delmonte, Marita Bosticardo, Mary Garofalo, Magda Carneiro-Sampaio, Raz Somech, Mohammad Gharagozlou, Nima Parvaneh, Lawrence E Samelson, Thomas A Fleisher, Anne Puel, Luigi Daniele Notarangelo, Bertrand Boisson, Jean-Laurent Casanova, Beata Derfalvi, Sergio D Rosenzweig
Inherited ARPC5 mutations cause an actinopathy impairing cell motility and disrupting cytokine signaling. Nature communications 14 (1) (2023)
Guillaume Gaud, Sooraj R Achar, François X P Bourassa, John S Davies, Teri Hatzihristidis, Seeyoung Choi, Taisuke Kondo, Selamawit Gossa, Jan Lee, Paul Juneau, Naomi Taylor, Christian S Hinrichs, Dorian B McGavern, Paul François, Grégoire Altan-Bonnet, Paul E Love
CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides. Nature immunology (2023)
Guillaume Gaud, Sooraj R Achar, François X P Bourassa, John S Davies, Teri Hatzihristidis, Seeyoung Choi, Taisuke Kondo, Selamawit Gossa, Jan Lee, Paul Juneau, Naomi Taylor, Christian S Hinrichs, Dorian B McGavern, Paul François, Grégoire Altan-Bonnet, Paul E Love
Publisher Correction: CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides. Nature immunology (2023)
Sooraj R Achar, François X P Bourassa, Thomas J Rademaker, Angela M Lee, Taisuke Kondo, Emanuel Salazar-Cavazos, John S Davies, Naomi Taylor, Paul François, Grégoire Altan-Bonnet
Universal antigen encoding of T cell activation from high-dimensional cytokine dynamics. Science (New York, N.Y.) 376 (6595) (2022)
John S Davies, Farrah Karimipour, Ling Zhang, Nisha Nagarsheth, Scott M Norberg, Carylinda Serna, Julius Strauss, Shinheng Chiou, James L Gulley, Christian S Hinrichs
Non-synergy of PD-1 blockade with T-cell therapy in solid tumors. Journal for immunotherapy of cancer 10 (7) (2022)
Ling Zhang, John S Davies, Carylinda Serna, Zhiya Yu, Nicholas P Restifo, Steven A Rosenberg, Richard A Morgan, Christian S Hinrichs
Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models. Journal for immunotherapy of cancer 8 (1) (2020)
Lillian Sun, Ellen Moore, Rose Berman, Paul E Clavijo, Anthony Saleh, Zhong Chen, Carter Van Waes, John S Davies, Jay Friedman, Clint T Allen
WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy. Oncoimmunology 7 (10) (2018)
Vesna Pulko, John S Davies, Carmine Martinez, Marion C Lanteri, Michael P Busch, Michael S Diamond, Kenneth Knox, Erin C Bush, Peter A Sims, Shripad Sinari, Dean Billheimer, Elias K Haddad, Kristy O Murray, Anne M Wertheimer, Janko Ž Nikolich
Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses. Nature immunology 17 (8) (2016)

John S Davies.css-eqlu8i{font-size:small;padding-left:4px;} (John Davies)

Publication Activity (10 Years)

Top Topics

Top Venues

John S Davies (John Davies)